Antimicrobial resistance is on the rise. But an initiative from Phare Bio, a biotech social venture founded in partnership with MIT, is leveraging generative AI to speed up discovery to create novel antibiotics. The team is also training AI to look for desired characteristics in new drugs, such as lower toxicity for vital organs, chemical stability, and better efficacy. Learn more about the technology that's accelerating new antibiotics coming to market to ensure superbugs don't win.